Tag - PVO

Feature

In conversation with Pivotal Therapeutics

By Len Zehr BioTuesdays.com recently sat down with the management team at Pivotal Therapeutics (OTCQX:PVTTF; CSE:PVO) to discuss the company’s VASCAZEN product that addresses Omega-3 deficiency in cardiovascular disease...

September 30, 2014

Feature

James Gandolfini’s death highlights risk factors for heart attack

By Len Zehr The recent and widely reported death of actor James Gandolfini highlights the need to aggressively address the known risk factors for heart attack and sudden cardiac death. “Omega-3 deficiency is one of...

July 9, 2013

Tag - PVO

In conversation with Pivotal Therapeutics

James Gandolfini’s death highlights risk factors for heart attack

General

More